Document is current
Any future updates will be listed below
-
Authors
Tesfaye, Markos https://orcid.org/0000-0002-3351-701X
Jaholkowski, Piotr
Hindley, Guy F. L.
Shadrin, Alexey A.
Rahman, Zillur
Bahrami, Shahram
Lin, Aihua
Holen, Børge
Parker, Nadine
Cheng, Weiqiu
Rødevand, Linn
Frei, Oleksandr
Djurovic, Srdjan
Dale, Anders M.
Smeland, Olav B.
O’Connell, Kevin S.
Andreassen, Ole A.
-
Funding
Funding for this research was provided by:
The Research Council of Norway (248980, 296030, 229129, 213837, 324252, 300309, 273291, 223273)
the American National Institutes of Health (NS057198, EB00790)
the South-East Norway Regional Health Authority (2022-073)
Stiftelsen Kristian Gerhard Jebsen (SKGJ-MED-021)
the European Union’s Horizon 2020 research and innovation program (847776, 964874)
University of Oslo
- License Information
-
More Information
Article History
Received: 3 May 2023
Accepted: 12 July 2023
First Online: 1 August 2023
Declarations
:
: Previously used datasets have been approved by their respective ethical approval committees. This research was conducted according to the Helsinki Declaration. The Regional Committee for Medical Research Ethics—South East Norway evaluated the current protocol and found that no additional institutional review board approval was necessary as no individual data were used.
: Not applicable.
: Ole A. Andreassen is a consultant for HealthLytix and has received speaker’s honoraria from Lundbeck and Sunovion. Srdjan Djurovic has received speaker’s Honoria from Lundbeck. Ander M. Dale is a founder of and holds equity in CorTechs Labs and serves on its scientific advisory board. He is also a member of the Scientific Advisory Board of Human Longevity, Inc., and receives research funding from General Electric Healthcare and Medtronic, Inc. The terms of these arrangements have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. The remaining authors declare that they have no competing interests.
